Precision Biosciences (DTIL) Capital Expenditures (2018 - 2026)
Precision Biosciences' Capital Expenditures came in at $18,000 for fiscal Q1 2026 (quarter ended Mar 31, 2026), down 71.9% from $64,000 a year earlier and down 5.3% from the prior quarter.
Powered by 
Analysis
Precision Biosciences (DTIL) Capital Expenditures (2018 - 2026) Analysis & Trends
For FY2025 (ended Dec 31, 2025), Precision Biosciences' Capital Expenditures was $85,000, down 66.0% from FY2024.
- Capital Expenditures has declined in each of the last four fiscal years, with a five-year compound annual growth rate of -55.8% (FY2020 to FY2025).
- Going back by fiscal year, Capital Expenditures was $250,000 in FY2024 (-87.2%), $1.96 million in FY2023 (-41.0%), $3.32 million in FY2022 (-34.3%) and $5.05 million in FY2021 (+0.4%).
- The five-year range for quarterly Capital Expenditures is -$26,000 (fiscal Q4 2023) to $1.69 million (fiscal Q2 2021).
- The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q3 2022 (growth of 48.7%), and the weakest in fiscal Q2 2024 (a decline of 97.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Precision Biosciences | 165.47 Mn | -183.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Sep 30, 2023 | 386,000.00 |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 521,000.00 |
| Dec 31, 2022 | 632,000.00 |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 779,000.00 |
| Mar 31, 2022 | 818,000.00 |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 733,000.00 |
| Jun 30, 2021 | 1.69 Mn |
| Mar 31, 2021 | 1.13 Mn |
API Access
Precision Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();